Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1090-1097
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1090
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1090
Table 1 Patient characteristics and prognoses
| Age | Sex | Macroscopic type | Histopathology | Metastasis | Number of courses | Objective tumor response | Prognosis (mo) | Conversion surgery | ||
| 1 | 64 | M | 3 | tub2/por | Liver, LNs | 7 | PR | 21.9 | Dead | |
| 2 | 59 | M | 3 | tub2/por | LNs | 5 | PR | 50.9 | Alive | Yes |
| 3 | 62 | M | 2 | por | Liver, LNs | 6 | SD | 7.4 | Dead | |
| 4 | 65 | M | 3 | por | LNs | 5 | PR | 7.7 | Dead | |
| 5 | 67 | F | 3 | tub2/por | LNs | 3 | non-CR/non-PD | 31.3 | Alive | Yes |
| 6 | 66 | M | 3 | por | LNs | 4 | non-CR/non-PD | 12.0 | Dead | |
| 7 | 62 | M | 2 | por | Liver, LNs | 3 | SD | 5.4 | Dead | |
| 8 | 63 | F | 2 | tub2/por | LNs | 4 | PR | 24.4 | Alive | Yes |
- Citation: Maeda O, Matsuoka A, Miyahara R, Funasaka K, Hirooka Y, Fukaya M, Nagino M, Kodera Y, Goto H, Ando Y. Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study. World J Gastroenterol 2017; 23(6): 1090-1097
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1090.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1090